Nitric oxide, but not vasopressin V2 receptor-mediated vasodilation, modulates vasopressin-induced renal vasoconstriction in rats

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 361, Issue 3, 2000, Pages 319-326

  Loichot, Cécile ^a,b   Cazaubon, Catherine ^c   De Jong, Wybren ^a   Helwig, Jean Jacques ^d   Nisato, Dino ^c   Imbs, Jean Louis ^a,b   Barthelmebs, Mariette ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^c SANOFI   (France)

^d INSERM   (France)

Author keywords

Anaesthesia; Brattleboro rats; Desmopressin; In vivo renal haemodynamics; Nitric oxide; Prostanoids; SR 49059; Vasopressin

Indexed keywords

DESMOPRESSIN; INDOMETACIN; N(G) NITROARGININE; NITRIC OXIDE; PROSTAGLANDIN SYNTHASE; RELCOVAPTAN; VASOPRESSIN; VASOPRESSIN V2 RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; DOSE RESPONSE; KIDNEY BLOOD FLOW; MALE; NONHUMAN; RAT; RENAL ARTERY; VASOPRESSIN BLOOD LEVEL;

EID: 0033955970     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002109900187     Document Type: Article

References (51)

1. 2 vasopressin-receptor-mediated renal vasodilatation. J Cardiovasc Pharmacol 23: 331-336
2. 8] vasopressin in the isolated perfused rat kidney. Eur J Pharmacol 314:325-332
3. Barthelmebs M, Helwig JJ, Nisato D, De Jong W, Grima M, Imbs JL (1997) Nitric oxide modulation of vasopressin-induced vasoconstriction in the isolated rat kidney depends on the viscosity of the perfusate (abstract). Br J Pharmacol 122:192P
4. Brink HS, Derkx FH, Boomsma F, Schalekamp MA (1994) Effects of DDAVP on renal hemodynamics and renin secretion in subjects with essential hypertension. Clin Nephrol 42:95-101
5. G-monomethyl-L-arginine and nitroarginine potentiate pressor responsiveness of vasoconstrictors in conscious rats. Am J Physiol 262:R1137-R1144
6. Cooper CL, Malik KU (1983) Mechanism of action of vasopressin on prostaglandin synthesis and vascular function in the isolated rat kidney: effect of calcium antagonists and calmodulin inhibitors. J Pharmacol Exp Ther 229:139-147
7. Corman B, Geelen G (1992) Effects of blood sampling, anesthesia and surgery on plasma vasopressin concentration in rats. Experentia 48:268-270
8. Cowley AW Jr, Monos E, Guyton AC (1974) Interaction of vasopressin and the baroreceptor reflex system in the regulation of arterial blood pressure in the dog. Circ Res 34:505-514
9. Davidge ST, Baker PN, McLaughlin MK, Roberts JM (1995) Nitric oxide produced by endothelial cells increases production of eicosanoids through activation of prostaglandin H synthase. Circ Res 77:274-283
10. Doni GM, Whittle BJR, Palmer RMJ, Moncada S (1988) Actions of nitric oxide on the release of prostacyclin from bovine endothelial cells in culture. Eur J Pharmacol 151:19-25
11. Edwards RM, Trizna W, Kinter LB (1989) Renal microvascular effects of vasopressin and vasopressin antagonists. Am J Physiol 256:F274-F278
12. 2 receptors and nitric oxide. Eur J Pharmacol 342:225-233
13. Garcia-Villalon AL, Garcia JL, Fernandez N, Monge L, Gomez B, Dieguez G (1996) Regional differences in the arterial response to vasopressin: role of the endothelial nitric oxide. Br J Pharmacol 118:1848-1854
14. G-nitro-L-arginine methyl ester or indomethacin on differential regional and cardiac haemodynamic actions of arginine vasopressin and lysine vasopressin in conscious rats. Br J Pharmacol 102:65-72
15. Harrison-Bernard LM, Carmines PK (1994) Juxtamedullary microvascular responses to arginine vasopressin in the rat kidney. Am J Physiol 267:F249-F256
16. Harrison-Bernard LM, Brizzee BL, Clifton GG, Walker BR (1990) Renal versus hindquarter hemodynamic response to vasopressin in conscious rats. J Cardiovasc Pharmacol 16:719-726
17. Heyndrickx GR, Boettcher DH, Vatner SF (1976) Effects of angiotensin, vasopressin, and methoxamine on cardiac function and blood flow distribution in conscious dogs. Am J Physiol 231:1579-1587
18. Hirata Y, Hayakawa H, Kakoki M, Tojo A, Suzuki E, Nagata D, Kimura K, Goto A, Kikuchi K, Nagano T, Hirobe M, Omata M (1997) Receptor subtype for vasopressin-induced release nitric oxide from rat kidney. Hypertension 29:58-64
19. Hofbauer KG, Dienemann H, Forgiarini P, Stadler R, Wood JM (1983) Renal vascular effects of angiotensin II, arginine-vasopressin and bradykinin in rats: interactions with prostaglandins. Gen Pharmacol 14:145-147
20. Hofbauer KG, Studer W, Mah SC, Michel JB, Wood JM, Stadler R (1984) The significance of vasopressin as a pressor agent. J Cardiovasc Pharmacol 6:S429-S438
21. Katusic ZS, Krstic MK (1987) Vasopressin causes endothelium-independent contractions of the rat arteries. Pharmacology 35: 264-271
22. Katusic ZS, Shepherd JT, Vanhoutte PM (1984) Vasopressin causes endothelium-dependent relaxations of the canine basilar artery. Circ Res 55:575-579
23. 1 receptor stimulation in rats. Am J Physiol 268:R796-R807
24. Lee SL, Levitsky S, Feinberg H (1989) Effects of exogenous vasoconstrictors on coronary vascular resistance and prostacyclin production of quiescent heart: the inhibitory effect of aspirin. J Pharmacol Exp Ther 248:44-49
25. Liard JF (1986) Cardiovascular effects associated with antidiuretic activity of vasopressin after blockade of its vasoconstrictor action in dehydrated dogs. Circ Res 58:631-640
26. Liard JF (1988) Characterization of acute hemodynamic effect of acute hemodynamic effects of antidiuretic agonists in conscious dogs. J Cardiovasc Pharmacol 11:174-180
27. Loichot C, Cazaubon C, Grima M, De Jong W, Nisato D, Imbs JL, Barthelmebs M (1999) Vasopressin does not effect hypertension caused by long-term nitric oxide inhibition. Hypertension (in press)
28. Manning RD, Hu L, Williamson TD (1994) Mechanisms involved in the cardiovascular-renal actions of nitric oxide inhibition. Hypertension 23:951-956
29. Marotta P, Sautebin L, Di Rosa M (1992) Modulation of the induction of nitric oxide synthase by eicosanoids in the murine macrophage cell line J774. Br J Pharmacol 107:640-641
30. Martinez MC, Vila JM, Aldasoro M, Medina P, Flor B, Lluch S (1994a) Relaxation of human isolated arteries by vasopressin and desmopressin. Br J Pharmacol 113:419-424
31. Martinez MC, Vila JM, Aldasoro M, Medina P, Lluch S (1994b) Responses to vasopressin and desmopressin of human cerebral arteries. J Pharmacol Exp Ther 270:622-627
32. 2-receptor-mediated relaxation of human renal arteries in response to desmopressin. Am J Hypertension 12:188-193
33. Montani JP, Liard JF, Schoun J, Möhring J (1980) Hemodynamic effects of exogenous and endogenous vasopressin at low plasma concentrations in conscious dogs. Circ Res 47:346-355
34. 2 receptors in conscious dogs. Am J Physiol 265:R934-R942
35. Nakanishi K, Mattson DL, Gross V, Roman RJ, Cowley AW Jr (1995) Control of renal medullary blood flow by vasopressin V1 and V2 receptors. Am J Physiol 269:R193-R200
36. Oliver JA, Sciacca RR, Le Cren G, Cannon PJ (1982) Modulation by prostaglandins of the renal vascular action of arginine vasopressin. Prostaglandins 24:641-656
37. Parekh N (1995) A novel method for infusing drugs continuously into the renal artery of rats. Am J Physiol 268:F967-F971
38. 2 receptors within the renal cortical and medullary circulation. Am J Physiol 273:R243-R251
39. Park F, Zou AP, Cowley AW Jr (1998) Arginine vasopressin-mediated stimulation of nitric oxide within the rat renal medulla. Hypertension 32:896-901
40. 2 receptor antagonism on renal function and response to vasopressin in conscious dogs. Am J Physiol 260:F273-F282
41. Rudichenko VM, Beierwaltes WH (1995) Arginine vasopressin-induced renal vasodilatation mediated by nitric oxide. J Vasc Res 32:100-105
42. Schini VB, Katusic ZS, Vanhoutte PM (1990) Neurohypophyseal peptides and tachykinins stimulate the production of cyclic GMP in cultured porcine aortic endothelial cells. J Pharmacol Exp Ther 255:994-1000
43. 1A receptors. J Clin Invest 92:224-231
44. Stadler J, Harbrecht BG, Di Silvio M, Curran RD, Jordan ML, Simmons RL, Billiar TR (1993) Endogenous nitric oxide inhibits the synthesis of cyclooxygenase products and interleukin-6 by rat Kuppfer cells. J Leukoc Biol 53:165-172
45. Takayasu M, Kajita Y, Suzuki Y, Shibuya M, Sugita K, Ishikawa T, Hidaka H (1993) Triphasic response of rat intracerebral arterioles to increasing concentrations of vasopressin in vitro. J Cereb Blood Flow Metab 13:304-309
46. 2 receptor stimulation in afferent arterioles. Kidney Int 49:722-729
47. Toda M, Ayajiki K, Okamura T, Azuma I, Toda N (1998) Desmopressin-induced dog ciliary artery relaxation. Eur J Pharmacol 344:197-201
48. Valtin H, Schroeder HA (1964) Familial hypothalamic diabetes insipidus in rats Brattleboro strain. Am J Physiol 206:425-430
49. Walker BR (1986) Evidence for a vasodilatory effect of vasopressin in the conscious rat. Am J Physiol 251:H34-H39
50. Weihprecht H, Lorentz JN, Briggs JP, Schnermann J (1991) Vasoconstrictor effect of angiotensin and vasopressin in isolated rabbit afferent arterioles. Am J Physiol 261:F273-F282
51. Ziyyat A, Zhang BL, Benzoni D (1996) Interactions between nitric oxide and prostanoids in the isolated perfused kidneys of the rat. Br J Pharmacol 119:388-392